Swift Biosciences will incorporate Horizon Discovery Group‘s human genomic reference standards into its new Accel-Amplicon 56G Oncology Panel for use in research and translational applications. The Accel-Amplicon 56G Oncology Panel is a single tube assay that offers comprehensive and hotspot coverage of 56 clinically relevant oncology-related genes, using a 263-amplicon design to generate multiplex libraries […]